Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2003
03/05/2003EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
03/05/2003EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives
03/05/2003EP1286995A1 2,7-naphthyridine derivatives
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286676A1 Bismuth compounds for the treatment and prevention of mucositis
03/05/2003EP1286658A2 Y-ifn liquid-droplet aerosol and method
03/05/2003EP1286657A1 Nasal ointment based on white petroleum jelly
03/05/2003EP1202984B1 diphenyl-piperidine derivate
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0964865B1 Pharmaceutically active tricyclic amines
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0831830B1 Imidazole compounds
03/05/2003EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof
03/05/2003EP0782441B1 Pharmaceutical control of inflammation
03/05/2003EP0667784B1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
03/05/2003CN1400975A 嘌呤衍生物 Purine derivatives
03/05/2003CN1400973A Novel biarylcarboxamides
03/05/2003CN1400910A Factor VII or VIIa like molecules
03/05/2003CN1400903A Novel combination of non sedative anti histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400017A Medicine for curing asthma disease
03/05/2003CN1400008A Medicine for curing nasal sinusitis
03/05/2003CN1400001A Medicine for curing cough and asthma
03/05/2003CN1399994A Medicine for curing nascsinusitis and its preparation method
03/05/2003CN1399985A Medicine for curing rhinitis and its preparation method
03/05/2003CN1399916A Application of dihydromyricetin in preparation of food, cosmetics or medicine
03/05/2003CN1399895A Spanish needles concentrated liquid tea
03/05/2003CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3
03/04/2003US6528677 Selective retinoid agonists
03/04/2003US6528522 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
03/04/2003US6528512 Cytokine specific binding protein;
03/04/2003US6528509 Pyrazole compositions useful as inhibitors of ERK
03/04/2003US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
03/04/2003US6528494 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
03/04/2003US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
03/04/2003CA1341424C Diketohexanoic acids and 2- and 3-diloweralkyl derivatives thereof
03/01/2003WO2003000027A2 Blocking peptide for inflammatory cell secretion
03/01/2003CA2452123A1 Blocking peptide for inflammatory cell secretion
02/2003
02/27/2003WO2003016567A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016528A2 Oligonucleotide compositions and their use to induce apoptosis
02/27/2003WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies
02/27/2003WO2003016346A1 Ligands
02/27/2003WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
02/27/2003WO2003016279A1 Fused-polycyclic compounds
02/27/2003WO2003016277A1 Cyclohept`b!indole derivatives as spla2 inhibitors
02/27/2003WO2003016269A1 5-amidino-n-(2-aminophenethyl)-n-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor
02/27/2003WO2003015805A1 Composition for removal of toxins
02/27/2003WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
02/27/2003WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
02/27/2003WO2003015793A1 Delayed and sustained drug release
02/27/2003WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
02/27/2003WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces
02/27/2003WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
02/27/2003WO2003015744A1 Chitin microparticles and their medical uses
02/27/2003WO2003015716A2 Immunoglobulin e vaccines and methods of use thereof
02/27/2003WO2003015711A2 Combination motif immune stimulatory oligonucleotides with improved activity
02/27/2003WO2003015707A2 Method for treating lung cancers
02/27/2003WO2003015494A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms
02/27/2003WO2003004098A8 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
02/27/2003WO2002094188A3 Methods for regulating bacteria
02/27/2003WO2002094180A3 Pharmaceutically active isoindoline derivatives
02/27/2003WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/27/2003WO2002089740A3 Sulfonamides
02/27/2003WO2002087511A3 Modulators of elastase inhibitor secretion
02/27/2003WO2002066420A3 Tryptase inhibitors
02/27/2003WO2002064590A3 Carboline derivatives
02/27/2003WO2002046193A3 Heterocyclic ether substituted imidazoquinolines
02/27/2003WO2002043695A3 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol
02/27/2003WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
02/27/2003WO2002028865A3 Condensed pyridoindole derivatives
02/27/2003WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
02/27/2003WO2002011711A3 Formulations of mometasone and a bronchodilator for pulmonary administration
02/27/2003WO2002000691A3 Polynucleotides and polypeptides encoded thereby
02/27/2003US20030040640 For use as anti- inflammatory analgesics, in therapy of immune disorders, as anti- cancer and anti-tumor agents, and therapy of cardiovascular disease, skin redness, and viral infection
02/27/2003US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
02/27/2003US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof
02/27/2003US20030040542 Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
02/27/2003US20030040541 Administering bismuth subgallate to inhibit the production of nitric oxide synthases (NOS)
02/27/2003US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease
02/27/2003US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity
02/27/2003US20030040517 For use in therapy of pain, fever, inflammation of a variety of conditions and diseases
02/27/2003US20030040513 P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
02/27/2003US20030040509 Methods and compositions for treating diseases associated with excesses in ACE
02/27/2003US20030040508 Altering the conformational equilibrium of the A- ring of a 1 alpha -hydroxylated vitamin D compound to favor a chair conformation for A-ring that presents the 1 alpha-hydroxyl in an axial orientation
02/27/2003US20030040487 Polymer complexes of glucuronoglucanes
02/27/2003US20030040468 For therapy of respiratory distress of the lungs
02/27/2003US20030040464 Method of treating or preventing attention defecit hyperactivity disorder
02/27/2003US20030040044 Anti-dual integrin antibodies, compositions, methods and uses
02/27/2003US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption
02/27/2003US20030039639 Isolated stromal cells for use in the treatment of diseases of the central nervous system
02/27/2003US20030039626 Fat-binding polymers
02/27/2003US20030039615 Method for treating bronchial constriction and bronchospasm
02/27/2003CA2493349A1 Delayed and sustained drug release
1 ... 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 ... 878